The Big Picture: Covid-19 and Longevity investingAuthor: Phil Newman | Published on: April 30, 2020 | Last updated: May 10, 2022 Jim MellonChairman and Founder, Burnbrae GroupThe Big Picture: Covid-19 and Longevity investing Share this article: Editor's choiceEmpowering cells to boost energy and recovery is a winning moveStudy disproves benefits of probiotics for vaginal healthHow do Tour De France athletes recover so fast? Performance coach reveals the secret9 proven ways to beat brain fog and enhance your energyLongevity investment platform opens-up to international investorsUrolithin A research opens door to osteoarthritis relief Popular articlesImpact of changes in the epigenome on agingVitaDAO closes $4.1 million fundraising roundLongevity Biomedical and SPAC Denali to create Nasdaq-listed longevity biopharm companyA decade of research expands the Hallmarks of Aging from nine to twelveLongevity investment bulletin: Juvena, eGenesis, Springs Rejuvenation and morePetr Sramek: Now is the right time to invest in longevity
